About i.Bioceuticals
i.Bioceuticals is a Healthcare company based in Orleans (United States) founded in 2009, and was acquired by Groupe Berkem in February 2023. Manufacturer of pine bark extracts. Its chief executive, as recorded, is Olivier Fahy. Its focus areas include Alternative Medicine Products.
Company details
i.Bioceuticals was founded in 2009 and is based in Orleans, United States. Operations are focused on the production of pine bark extracts within the nutraceutical industry. Natural ingredients are processed through extraction methods to support health-related applications. The company is led by CEO Olivier Fahy, with activities centered on manufacturing for various markets. Geographic emphasis remains on domestic production facilities.
- Headquarters Orleans, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ibioceuticals.com
- Acquired by Groupe Berkem (Feb 2023)
- Investors
- Acquired byGroupe Berkem
(Feb 2023)
Investors in i.Bioceuticals
i.Bioceuticals has secured backing from 1 investor. Prominent investors backing the company include Groupe Berkem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of natural active ingredients and plant extracts for cosmetics and food industries | 2013 | groupeberkem.com | Blanquefort, France |
Investor details for i.Bioceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of i.Bioceuticals
1 people are tracked at i.Bioceuticals (1 in leadership).
| Name | Role | Group |
|---|---|---|
Olivier Fahy | CEO | Leadership |
Complete people profiles for i.Bioceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of i.Bioceuticals
2 dated milestones of i.Bioceuticals across 14 years, from founding to its latest funding, stage changes and deals.
- Founded i.Bioceuticals is founded.
- Exit Acquired by Groupe Berkem.
Top companies in Alternative Medicine Products
3 companies that operate in the same segment as i.Bioceuticals (Alternative Medicine Products) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical therapies for smell and taste loss are developed. | 2014 | Washington, District Of Columbia, United States | USD 25.88 M | |||
Homeopathic medicines are supplied and distributed by Boiron worldwide. | 1932 | Newtown Square, Pennsylvania, United States | ||||
Manufacturer of herbal medicines | 2009 | Wilmington, Delaware, United States | USD 2.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about i.Bioceuticals
i.Bioceuticals was founded in 2009.
i.Bioceuticals is headquartered in Orleans, United States. It is registered at Orleans, Massachusetts, United States.
Olivier Fahy is the CEO of i.Bioceuticals, as recorded in our data.
i.Bioceuticals was founded in 2009 and is based in Orleans, United States. Operations are focused on the production of pine bark extracts within the nutraceutical industry. Natural ingredients are processed through extraction methods to support health-related applications. The company is led by CEO Olivier Fahy, with activities centered on manufacturing for various markets. Geographic emphasis remains on domestic production facilities.
i.Bioceuticals has 1 investor. Key investors include Groupe Berkem.
Yes. i.Bioceuticals was acquired by Groupe Berkem in February 2023.